iFlytek Healthcare Technology (02506.HK): Plans to implement full circulation of H shares

Zhitong Finance APP News, iFlytek Healthcare Technology (02506.HK) announced that the company has submitted an application to the China Securities Regulatory Commission to convert 35,119,600 domestic shares of the company into H shares. After obtaining the filing and/or approval of all relevant regulatory authorities (including but not limited to the China Securities Regulatory Commission and the Stock Exchange) and complying with all applicable laws and regulations, such unlisted shares will be converted into H shares and become eligible for listing and trading on the Main Board of the Stock Exchange. According to the company's articles of association, no further shareholders' meeting is required to approve the conversion and listing.